Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Hoffmann Rolf K, Director. Insider active across 1 company, notably Paratek Pharmaceuticals, Inc.. Cumulatively, 3 filings have been published. Activity tracked since 16 February 2022. The latest transaction was disclosed on 8 February 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Rolf K. Hoffmann is a Board Member at Paratek Pharmaceuticals, Inc. He brings expertise in corporate governance and pharmaceutical strategy. His role as a board member allows him to contribute to strategic decision-making and the direction of the company.